ArticleTherapeutic advances in gastroenterology2009
Sequential Therapy for Helicobacter Pylori Eradication: The Time is Now!
Article in Therapeutic advances in gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Article
- The Helicobacter pylori AI-clinician harnesses artificial intelligence to personalise H. pylori treatment recommendations.Nature communications · 2025Article
- Efficacy and Safety of 10-Day Versus 14-Day Bismuth-Containing Quadruple Therapy forJGH open : an open access journal of gastroenterology and hepatology · 2025Review
- Addressing Challenges in Standardizing Helicobacter pylori Treatment Protocols: Importance and Review.Cureus · 2024Review
- Efficacy and tolerability ofHealth science reports · 2024Article
- Sequential versus Standard Triple Therapy for First-LineAntibiotics (Basel, Switzerland) · 2024Review
- Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pylori.Cureus · 2023Review
- Article
- Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy forMiddle East journal of digestive diseases · 2018Article
- First-line therapies forAnnals of gastroenterology · 2017Review
- Hybrid Therapy Regimen for Helicobacter Pylori Eradication.Chinese medical journal · 2016Review
- Treatment of Helicobacter pylori infection: Current and future insights.World journal of clinical cases · 2016Review
- Optimal First-Line Treatment forGastroenterology research and practice · 2016Review
- Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management.Biomarker research · 2016Review
- Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages.PLoS biology · 2015Article
- Testing the optimality properties of a dual antibiotic treatment in a two-locus, two-allele model.Journal of the Royal Society, Interface · 2014Article
- Role of gastritis pattern on Helicobacter pylori eradication.Internal and emergency medicine · 2012Article
- Helicobacter pylori therapy: Present and future.World journal of gastrointestinal pharmacology and therapeutics · 2012Article
- Newer agents for Helicobacter pylori eradication.Clinical and experimental gastroenterology · 2012Article
- Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study.Gastroenterology research and practice · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.